Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001140361-25-020208
Filing Date
2025-05-22
Accepted
2025-05-22 17:27:39
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 ny20048719x1_424b5.htm 424B5 529562
2 logo_gyrex1.jpg GRAPHIC 27505
3 logo_gyrex2.jpg GRAPHIC 38358
4 logo_gyrex5.jpg GRAPHIC 58937
  Complete submission text file 0001140361-25-020208.txt   702164
Mailing Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130
Business Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130 (619) 949-3681
GYRE THERAPEUTICS, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-283237 | Film No.: 25978356
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)